Discover open access scientific publications

Search, annotate, share and cite publications

Publications by M. Ychou

Sorafenib Overcomes Irinotecan Resistance in Colorectal Cancer by Inhibiting the ABCG2 Drug-Efflux Pump

Molecular Cancer Therapeutics

Cancer Research

Oncology

2013

English

P-161 * a Phase I-Trial Assessing Several Schedules of Oral S-1 Combined With Fixed Doses of Oxaliplatin and Irinotecan in Patients With Advanced or Metastatic Digestive Adenocarcinoma as First- Or Second-Line Treatment

English

Related publications

Bafetinib (INNO-406) Reverses Multidrug Resistance by Inhibiting the Efflux Function of ABCB1 and ABCG2 Transporters

Scientific Reports

Multidisciplinary

2016

English

Gambogic Acid Inhibits Growth, Induces Apoptosis, and Overcomes Drug Resistance in Human Colorectal Cancer Cells

International Journal of Oncology

Cancer Research

Oncology

2015

English

Drug Efflux Pump Expression in 50,000 Molecularly-Profiled Cancer Patients.

Journal of Clinical Oncology

English

Chrysin Overcomes TRAIL Resistance of Cancer Cells Through McL-1 Downregulation by Inhibiting STAT3 Phosphorylation

International Journal of Oncology

Cancer Research

Oncology

2013

English

RhoA Regulates Resistance to Irinotecan by Regulating Membrane Transporter and Apoptosis Signaling in Colorectal Cancer

Oncotarget

Oncology

2016

English

TARBP2-mediated Destabilization of Nanog Overcomes Sorafenib Resistance in Hepatocellular Carcinoma

English

Neoadjuvant Endocrine Therapy in Breast Cancer Up-Regulates the Cytotoxic Drug Pump ABCG2 /BCRP, and May Lead to Resistance to Subsequent Chemotherapy

Clinical Breast Cancer

Cancer Research

Oncology

2018

English

Bevacizumab May Overcome Clinical Tumor Drug Resistance to Irinotecan Based Chemotherapy in Patients With Metastatic Colorectal Cancer: Case Report

The Open Colorectal Cancer Journal

2010

English

FL118, a Novel Camptothecin Derivative, Is Insensitive to ABCG2 Expression and Shows Improved Efficacy in Comparison With Irinotecan in Colon and Lung Cancer Models With ABCG2-induced Resistance

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by M. Ychou

Sorafenib Overcomes Irinotecan Resistance in Colorectal Cancer by Inhibiting the ABCG2 Drug-Efflux Pump

P-161 * a Phase I-Trial Assessing Several Schedules of Oral S-1 Combined With Fixed Doses of Oxaliplatin and Irinotecan in Patients With Advanced or Metastatic Digestive Adenocarcinoma as First- Or Second-Line Treatment

Related publications

Bafetinib (INNO-406) Reverses Multidrug Resistance by Inhibiting the Efflux Function of ABCB1 and ABCG2 Transporters

Gambogic Acid Inhibits Growth, Induces Apoptosis, and Overcomes Drug Resistance in Human Colorectal Cancer Cells

Drug Efflux Pump Expression in 50,000 Molecularly-Profiled Cancer Patients.

Chrysin Overcomes TRAIL Resistance of Cancer Cells Through McL-1 Downregulation by Inhibiting STAT3 Phosphorylation

RhoA Regulates Resistance to Irinotecan by Regulating Membrane Transporter and Apoptosis Signaling in Colorectal Cancer

TARBP2-mediated Destabilization of Nanog Overcomes Sorafenib Resistance in Hepatocellular Carcinoma

Neoadjuvant Endocrine Therapy in Breast Cancer Up-Regulates the Cytotoxic Drug Pump ABCG2 /BCRP, and May Lead to Resistance to Subsequent Chemotherapy

Bevacizumab May Overcome Clinical Tumor Drug Resistance to Irinotecan Based Chemotherapy in Patients With Metastatic Colorectal Cancer: Case Report

FL118, a Novel Camptothecin Derivative, Is Insensitive to ABCG2 Expression and Shows Improved Efficacy in Comparison With Irinotecan in Colon and Lung Cancer Models With ABCG2-induced Resistance